E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study
Pathology - Research and Practice · 2025
DOI: 10.1016/j.prp.2025.156160 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Natalia Pérez-Barraza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile; Facultad de Medicina, Escuela de Me…. Hauptthemen laut MEDLINE: Cadherins, Prostatic Neoplasms, Biomarkers, Tumor, Antigens, CD. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: Universidad de Valparaíso, Centro Singular de Investigación de Galicia, Centros de Investigación y Desarrollo, Universidad de Valparaíso.
Abstract (Originalsprache)
Prostate cancer (PC) is the most prevalent cancer and the second leading cause of death in males worldwide. One of the processes responsible for its mortality is the metastasizing capacity of malignant cells, which is associated with the epithelial-mesenchymal transition process (EMT). EMT is a physiological process during embryogenesis, with loss of cell adhesion molecules such as cadherins, and overexpression of molecules associated with invasive behaviour, such as matrix metalloproteinases (MMPs). We analyzed 321 tissue samples using immunohistochemistry. E-cadherin expression was significantly lower in PC than in BPH (107.1 ± 60.0 vs. 139.99 ± 36.65; p 0.17). N-cadherin and ADAM12 showed statistically significant associations with PSA (p = 0.038 and p = 0.013, respectively) but not with other clinical variables. These findings support the involvement of EMT-related markers in PC and suggest their potential utility in biological characterization, although further studies are required to determine their prognostic value.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Interdisciplinary Centre for Health Studies (CIESAL), Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile; Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile. El…
- Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile. Electronic address: sebastianconcha1991@gmail.com.
- Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile. Electronic address: pantonioag@yahoo.com.
- Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile; Centro Interdisciplinario de Investigación Biomédica e Ingeniería para la Salud MEDING, Universidad de Valparaíso, C…
- Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile. Electronic address: juan.varas@uv.cl.
- Facultad de Medicina, Escuela de Medicina, Universidad de Valparaíso, Viña del Mar, Valparaíso, Chile. Electronic address: diego.toledo@alumnos.uv.cl.
Förderung
- Universidad de Valparaíso
- Centro Singular de Investigación de Galicia
- Centros de Investigación y Desarrollo, Universidad de Valparaíso
Zitieren
APA
Pérez-Barraza, N., Concha, S., Acuña, P., Martín, S. S., Córdova, C., Varas, J., Toledo, D., & Madrid, E. (2025). E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.156160
Vancouver
Pérez-Barraza N, Concha S, Acuña P, Martín SS, Córdova C, Varas J, et al. E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.156160
BibTeX
@article{PrezBarraza2025,
author = {Pérez-Barraza, Natalia and Concha, Sebastián and Acuña, Pedro and Martín, Sebastián San and Córdova, Claudio and Varas, Juan and Toledo, Diego and Madrid, Eva},
title = {E-cadherin, N-cadherin and ADAM12 in localized prostate cancer: A clinicopathological study},
journal = {Pathology - Research and Practice},
year = {2025},
doi = {10.1016/j.prp.2025.156160}
}
EUVIMED